VIROFEND THERAPEUTICS TEAM

Computational Biologist with expertise in Artificial Intelligence and Computational Biology. Brings over six years of experience leading biotechnology teams ranging from 18 to 120 professionals, with a proven track record in managing complex R&D environments and coordinating multidisciplinary projects. Has successfully prepared, presented, coordinated, and justified research and innovation projects totaling several million. Combines strategic management capabilities with deep technical expertise to drive innovation and organizational efficiency.

Currently serves as Director of Operations and R&D (Deputy General Director) at Virofend Therapeutics, overseeing the R&D and Project divisions, defining strategic priorities, and fostering collaboration across departments to enhance the company’s scientific impact and operational performance.

Economist and MBA with a solid track record in corporate finance, financial statement analysis, budgeting, forecasting and management control, as well as supervising teams and processes in complex business environments. He has developed his career in industrial, pharmaceutical and consulting companies, taking on financial management responsibilities and contributing to strategic decision-making.

As Business Development Director at ViroFend Therapeutics, he leads financial planning and strategic analysis, supporting the design of business models, the evaluation of investments and the definition of the company’s growth plans, to which he brings a strong analytical vision and a focus on long-term value creation.

Holding a degree in Political Science from the University of Salamanca and an MBA, she brings a consolidated trajectory with over 10 years of experience in strategic management, business development, and client relations optimization. She possesses a solid background in Human Resources and holds key certifications, in addition to a high level of proficiency in both English and French.

She currently serves as Chief Negotiating and Strategic Development Officer at ViroFend Therapeutics, contributing to the company's operational and strategic structure. Previously, she was a Head Project Manager, successfully leading the management of complex projects, designing campaign strategies, and being instrumental in sales pipeline growth. Her experience includes managing business units across sales (SDR), key accounts, and operations. She combines the ability to lead teams with the strategic vision necessary to deliver value to every stakeholder.

Biologist with a PhD in Biomedicine and extensive experience in clinical research and coordination of clinical trials across various therapeutic areas. She brings solid expertise in monitoring, documentation validation and ICH-GCP compliance, along with strong skills in scientific communication and collaboration with healthcare and research teams. As Lead Project Manager at ViroFend Therapeutics, she oversees the planning, supervision and follow-up of clinical programs, ensuring rigorous execution aligned with the company’s scientific and regulatory objectives.

Her multidisciplinary background strengthens ViroFend’s transition into clinical development and supports the advancement of its innovative oncolytic therapies.

Biochemist and Doctor of Neuroscience, with more than 8 years of experience in pre-clinical research and operations in the therapeutic area of Oncology. She has participated in the publication of articles in high-impact journals and in the development of a patent, combining scientific rigour with a clear focus on results. Throughout her career, she has promoted medical and scientific communication, generating specialised materials and giving presentations, as well as strengthening her work with healthcare professionals and multidisciplinary teams.

She has direct experience in project management and cross-functional coordination in pharmaceutical environments, aligning activities between different areas and simultaneously managing multiple clinical projects. Her profile is characterised by a solid scientific and technical foundation, organisational and prioritisation skills, and a practical approach focused on the efficient execution of clinical projects, with specific training in Good Clinical Practices (GCP/ICH).

She currently serves as a Clinical Project Manager at ViroFend, contributing to the company’s clinical development activities and to the translation of preclinical development results into patient-focused clinical applications.

Biotechnologist and PhD in Neuroscience, with experience in preclinical research in the fields of neuroscience and oncology and a strong translational focus. She has developed her career in academic settings and international research centers, participating in competitive research projects and contributing to scientific publications in international journals, within pharmacological and experimental studies conducted with a rigorous and applied approach.

As a Postdoctoral Researcher at ViroFend Therapeutics, she is involved in the development and preclinical validation of novel therapeutic strategies, contributing her experimental and analytical expertise to the advancement of the company’s R&D programs.

Pharmacist with an MBA in Biopharmaceutical Companies and specialized training in the management of international R&D projects. She brings solid experience in pharmaceutical operations, biotechnology project coordination and strategic planning, integrating technical knowledge with strong organizational and analytical capabilities, as well proven expertise in industrial development and scale—up processes.

As Project Manager at ViroFend Therapeutics, she supports the design, coordination and follow-up of R&D activities, ensuring efficient project execution and alignment with the company’s scientific and operational objectives. Her multidisciplinary background contributes to strengthening ViroFend’s development pathways and to boosting the progress of its production programs.

Biologist with over ten years of experience in quality control and laboratory environments, including microbiological and physicochemical analysis, raw material control and participation in audits and certifications such as IFS and Global GAP. She has developed her career in regulated settings, ensuring compliance, traceability and quality standards, while working closely with multidisciplinary teams.

At ViroFend Therapeutics, she joins as Quality Technician, taking part in regulatory and quality activities related to manufacturing and clinical development, supporting the implementation of robust quality systems and ensuring alignment with preclinical and clinical requirements for our project.

Biologist with a Master’s in Molecular and Health Biology, with experience in virology, bioinformatics, and molecular techniques. Has developed research work at the University of Salamanca, contributing to projects focused on rare diseases and applying various analytical tools. Brings a versatile profile, adaptability in dynamic scientific environments, and fluency in multiple languages.

Currently works as a Bioinformatics Analyst at ViroFend Therapeutics, where she supports the design, technical implementation, and execution of R&D lines with strong translational potential.

Biotechnologist with postgraduate training in Drug Evaluation and Development, oriented toward the pharmaceutical industry. She has experience in R&D project management, having served as a Project Manager within the biotechnology field. She has gained research experience at institutions such as the Faculty of Medicine of Albacete and the Cancer Research Center (CIC) in Salamanca.

She currently holds the position of Clinical Trial Assistant at Virofend Therapeutics, where she is involved in the coordination and monitoring of projects. Her profile is characterized by a strong scientific and technical background, solid organizational skills, and a clear focus on the efficient management of research and development projects.

Biotechnologist with a strong academic background, holding a degree in Biotechnology from the University of Extremadura and the Polytechnic Institute of Setúbal, and a Master’s in Cellular and Molecular Biology from the University of Salamanca. She has gained research experience in institutions such as IBGM (CSIC/UVa) and Hospital Virgen de la Vega (IBSAL), and holds certification for animal experimentation. Her profile combines scientific knowledge with strong organizational, planning and teamwork skills.

At ViroFend Therapeutics, she works as Clinical Trial Assistant, supporting the technical and operational aspects of clinical studies and acting as a key link between preclinical research and clinical development, contributing to the efficient translation of scientific advances into clinical application.

Biotechnologist with a University Master’s Degree in Cell and Molecular Biology, with a strong foundation in biomedical research and molecular oncology. She developed a research project at the Cancer Research Center (CIC) in Salamanca focused on the analysis of immune factors in multiple myeloma patients. She also gained clinical experience at the University Hospital of Badajoz (HUB), working on biological sample processing and diagnostic testing.

At ViroFend Therapeutics, she works as Clinical Trial Assistant, supporting R&D activities and contributing to the technical and operational aspects of clinical studies, facilitating the integration between research, development and clinical execution through a structured and methodical approach.

Irina Stefana is a biologist and holds a PhD in Cellular, Molecular, and Genetic Biology, with nearly fifteen years of experience in biomedical research and innovation management. Her career combines a strong scientific background with specialization in intellectual property and biotechnology strategy, covering areas such as cell biology, genetics, metabolism, neurodegenerative diseases, and technology transfer within the life sciences sector.

As an advisor at Virofend Therapeutics, she applies her scientific and technical expertise to the protection and strategic management of the company’s innovation assets. Through her work, she helps establish robust processes for innovation capture, data confidentiality, and regulatory compliance, ensuring that Virofend’s technological advances are effectively protected and positioned for clinical and commercial success.